Group One Trading
GNMK

Group One Trading’s GenMark Diagnostics, Inc GNMK Stock Holding History

Group One Trading’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,288
Closed -$31K – 8861
2021
Q1 		$31K Sell
1,288
-19,720
-94% -$367K ﹤0.01% 6544
2020
Q4 		$307K Buy
+21,008
New +$278K ﹤0.01% 3717
2020
Q3 		– Sell
-18,249
Closed -$279K – 6779
2020
Q2 		$268K Buy
+18,249
New +$185K ﹤0.01% 3146
2017
Q1 		– Sell
-300
Closed -$3.61K – 5171
2016
Q4 		$4K Buy
+300
New +$3.56K ﹤0.01% 4167
2015
Q4 		– Sell
-4,900
Closed -$39K – 5277
2015
Q3 		$39K Buy
4,900
+4,112
+522% +$38K ﹤0.01% 3685
2015
Q2 		$7K Buy
+788
New +$7.95K ﹤0.01% 4412
2013
Q4 		– Sell
-2,250
Closed -$27.3K – 5657
2013
Q3 		$27K Sell
2,250
-1,100
-33% -$11.8K ﹤0.01% 3989
2013
Q2 		$35K Buy
+3,350
New +$46.2K ﹤0.01% 3728

Group One Trading's GNMK Position: Q2 2021 in Review

Group One Trading sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,288 shares — an estimated $31K sold.

Group One Trading first reported a position in GNMK in Q2 2013 and held it in 8 quarters. The position peaked at $307K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Group One Trading reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Group One Trading sold 1,288 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $31K.
  • Group One Trading first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 8 quarters.
  • Group One Trading's GenMark Diagnostics, Inc position peaked at $307K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.